Symptomatic Therapy

Symptomatic Therapy is a therapeutic approach in neurodegenerative disease pharmacotherapy that belongs to the class of treatments aimed at alleviating clinical manifestations of the disease, specifically distinguished by its focus on mitigating symptoms rather than modifying the underlying neurodegenerative process.

2.5K

Publications

144.6K

Citations

11.4K

Authors

3K

Institutions

Publications per year

2017–2026

429

Variants

Symptomatic Treatment

Authors

11.4K

  1. CW
    C. Warren Olanow

    Icahn School of Medicine at Mount Sinai, United States

    6 publications · 584 citations

    6

    h-index

  2. RW
    Richard W. McCallum

    Texas Tech University, United States

    6 publications · 711 citations

    6

    h-index

  3. RA
    Robert A. Hauser

    University of South Florida, United States

    6 publications · 573 citations

    6

    h-index

  4. TL
    Thomas L. Abell

    University of Louisville, United States

    6 publications · 264 citations

    6

    h-index

  5. JE
    Joel E. Richter

    Cleveland Clinic, United States

    5 publications · 618 citations

    5

    h-index

1–5 of 11.4K

Venues

  1. PubMed

    Repository · 326 publications · 12K citations

    54

    h-index

  2. Neurology

    37 publications · 6.1K citations

    31

    h-index

  3. Gut

    29 publications · 3.2K citations

    27

    h-index

  4. Alimentary Pharmacology & Therapeutics

    36 publications · 2.2K citations

    27

    h-index

  5. JAMA

    40 publications · 3.4K citations

    25

    h-index

1–5